CLINICAL_TRIALS
trial_result
· 2025-05-31
Clinical Trial Update: Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME [NA]
Summary
A completed clinical study evaluated the Everads Injector for suprachoroidal administration of triamcinolone acetonide suspension in diabetic macular edema. The…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Everads Therapy | Conditions: Diabetic Macular Edema | NA | Status: COMPLETED